Willkie Farr & Gallagher LLP represented Innoviva in the transaction, while Kirkland & Ellis advised GlaxoSmithKline. Innoviva, Inc. (NASDAQ: INVA) executed definitive agreement to purchase Glaxo…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
